Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Beran

Showing results (231-240 of 251) with videos related to

Pageof 26
Sort By:
Cancer|August 15, 1988
Mitoxantrone and high-dose cytosine arabinoside in refractory acute myelogenous leukemiaR S Walters, H M Kantarjian, M J Keating, et al.
Bone Marrow Transplantation|March 30, 2004
Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemiaP Mittal, R M Saliba, S A Giralt, et al.
Blood|October 1, 1996
Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemiaM Beran, H Kantarjian, S O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Troxacitabine, a novel dioxolane nucleoside analog, has activity in patients with advanced leukemiaF J Giles, J E Cortes, S D Baker, et al.
Cancer|October 12, 2001
High-dose chemotherapy in high-risk myelodysplastic syndrome: covariate-adjusted comparison of five regimensM Beran, Y Shen, H Kantarjian, et al.
Blood|July 1, 1994
Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemiaS M Kornblau, H J Xu, W Zhang, et al.
Blood|February 1, 1995
Molecular characterization of 16p deletions associated with inversion 16 defines the critical fusion for leukemogenesisP Marlton, D F Claxton, P Liu, et al.
Leukemia|May 1, 1987
The localization of the human myeloperoxidase gene is in close proximity to the translocation breakpoint in acute promyelocytic leukemiaK S Chang, W Schroeder, M J Siciliano, et al.
Blood|December 3, 1998
Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor is toxic to blasts from patients with juvenile myelomonocytic leukemia and chronic myelomonocytic leukemiaA E Frankel, M Lilly, R Kreitman, et al.
Blood|February 15, 1992
Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA)E H Estey, R Kurzrock, H M Kantarjian, et al.
Pageof 26

Showing results (231-240 of 251) with videos related to

Sort By:
Pageof 26
Cancer|August 15, 1988
Mitoxantrone and high-dose cytosine arabinoside in refractory acute myelogenous leukemiaR S Walters, H M Kantarjian, M J Keating, et al.
Bone Marrow Transplantation|March 30, 2004
Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemiaP Mittal, R M Saliba, S A Giralt, et al.
Blood|October 1, 1996
Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemiaM Beran, H Kantarjian, S O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Troxacitabine, a novel dioxolane nucleoside analog, has activity in patients with advanced leukemiaF J Giles, J E Cortes, S D Baker, et al.
Cancer|October 12, 2001
High-dose chemotherapy in high-risk myelodysplastic syndrome: covariate-adjusted comparison of five regimensM Beran, Y Shen, H Kantarjian, et al.
Blood|July 1, 1994
Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemiaS M Kornblau, H J Xu, W Zhang, et al.
Blood|February 1, 1995
Molecular characterization of 16p deletions associated with inversion 16 defines the critical fusion for leukemogenesisP Marlton, D F Claxton, P Liu, et al.
Leukemia|May 1, 1987
The localization of the human myeloperoxidase gene is in close proximity to the translocation breakpoint in acute promyelocytic leukemiaK S Chang, W Schroeder, M J Siciliano, et al.
Blood|December 3, 1998
Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor is toxic to blasts from patients with juvenile myelomonocytic leukemia and chronic myelomonocytic leukemiaA E Frankel, M Lilly, R Kreitman, et al.
Blood|February 15, 1992
Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA)E H Estey, R Kurzrock, H M Kantarjian, et al.
Pageof 26